Specificities of Protein Homology Modeling for Allosteric Drug Design

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The allosteric binding sites are usually located in the flexible areas of proteins, which are hardly visible in the crystal structures. However, there are notable exceptions like allosteric sites in receptors in class B and C of GPCRs, which are located within a well-defined bundle of transmembrane helices. Class B and C evolved from class A and even after swapping of orthosteric and allosteric sites the central binding site persisted and it can be used for easy design of allosteric drugs. However, studying the ligand binding to the allosteric sites in the most populated class A of GPCRs is still a challenge, since they are located mostly in unresolved parts of the receptor’s structure, and especially N-terminus. This chapter provides an example of cannabinoid CB1 receptor N-terminal homology modeling, ligand-guided modeling of the allosteric site in GABA receptor, as well as C-linker modeling in the potassium ion channels where the allosteric phospholipid ligand PIP2 is bound.

Cite

CITATION STYLE

APA

Jakowiecki, J., Orzeł, U., Gliździnska, A., Możajew, M., & Filipek, S. (2023). Specificities of Protein Homology Modeling for Allosteric Drug Design. In Methods in Molecular Biology (Vol. 2627, pp. 339–348). Humana Press Inc. https://doi.org/10.1007/978-1-0716-2974-1_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free